RecruitingNCT07402954
Safety and feasibility of artery stimulation for treatment-resistant migraine
About this title
Read the official source — NCT07402954Device studyAges 18–100United StatesBipolarity
Understand this study
Who could participate?
Listed age limits: 18 years to 100 years.
What will I do during this study?
Adults with chronic migraine, status migrainosus, or certain persistent facial pain who are already scheduled for an intra-arterial lidocaine infusion may be eligible for this Galveston study. Before the planned infusion, clinicians apply electrical pulses through the external carotid circulation and monitor vital signs, neurological status, and headache severity. The study is evaluating this procedure; it has not established that it improves headaches. Other eligibility criteria apply.
- Listed locations
- GalvestonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 16, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 12
- Sponsor
- The University of Texas Medical Branch, Galveston
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 100 Years
- Official registry ID
- NCT07402954
- Official title
Show the full official title
Feasibility and Safety of Endovascular Bipolar Stimulation of the Middle Meningeal Artery for Refractory Headaches (MMA-Stim)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Galveston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Medical Branch, Galveston, a university.
Who can participate?
Listed age limits: 18 years to 100 years.
Is this study still recruiting?
The registry lists this study as recruiting.
